US Bancorp’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438 | Hold |
151
| – | – | ﹤0.01% | 4012 |
|
|
2025
Q1 | $109 | Sell |
151
-5,000
| -97% | -$3.61K | ﹤0.01% | 4119 |
|
|
2024
Q4 | $5.31K | Buy |
5,151
+5,000
| +3,311% | +$5.15K | ﹤0.01% | 3631 |
|
|
2024
Q3 | $202 | Hold |
151
| – | – | ﹤0.01% | 3991 |
|
|
2024
Q2 | $196 | Hold |
151
| – | – | ﹤0.01% | 3885 |
|
|
2024
Q1 | $260 | Hold |
151
| – | – | ﹤0.01% | 3887 |
|
|
2023
Q4 | $222 | Hold |
151
| – | – | ﹤0.01% | 3887 |
|
|
2023
Q3 | $183 | Hold |
151
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q2 | $219 | Hold |
151
| – | – | ﹤0.01% | 3886 |
|
|
2023
Q1 | $219 | Hold |
151
| – | – | ﹤0.01% | 3993 |
|
|
2022
Q4 | $261 | Hold |
151
| – | – | ﹤0.01% | 4023 |
|
|
2022
Q3 | $0 | Hold |
151
| – | – | ﹤0.01% | 4178 |
|
|
2022
Q2 | $0 | Sell |
151
-1,000
| -87% | – | ﹤0.01% | 4184 |
|
|
2022
Q1 | $10K | Hold |
1,151
| – | – | ﹤0.01% | 3362 |
|
|
2021
Q4 | $18K | Buy |
1,151
+151
| +15% | +$2.36K | ﹤0.01% | 3154 |
|
|
2021
Q3 | $18K | Sell |
1,000
-2,000
| -67% | -$36K | ﹤0.01% | 3170 |
|
|
2021
Q2 | $42K | Hold |
3,000
| – | – | ﹤0.01% | 2752 |
|
|
2021
Q1 | $44K | Hold |
3,000
| – | – | ﹤0.01% | 2635 |
|
|
2020
Q4 | $58K | Hold |
3,000
| – | – | ﹤0.01% | 2446 |
|
|
2020
Q3 | $33K | Buy |
3,000
+2,000
| +200% | +$22K | ﹤0.01% | 2557 |
|
|
2020
Q2 | $14K | Buy |
1,000
+500
| +100% | +$7K | ﹤0.01% | 2920 |
|
|
2020
Q1 | $4K | Hold |
500
| – | – | ﹤0.01% | 3261 |
|
|
2019
Q4 | $5K | Hold |
500
| – | – | ﹤0.01% | 3232 |
|
|
2019
Q3 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 3253 |
|